In Depth
Fetal Deaths At Less Than 20 Weeks Gestation
Richard M. Pauli, M.D., Ph.D.
Introduction. Most intrauterine deaths occur
during the first trimester. Far fewer are miscarried in
the 13-20 week span of early mid-gestation. Each of these
circumstances, as well as stillbirth per se (death at 20
weeks or more gestation), have different underlying
causes and, hence, demand different methods of
evaluation. This In Depth tackles the issue of how
intrauterine deaths prior to twenty weeks should be
assessed.
Pre-early losses. Recent studies, using
sensitive methods to detect exceedingly early hormonal
changes, have allowed estimation of the proportion of
pregnancies which are spontaneously aborted prior to
implantation (and prior to the time when pregnancy is
normally detected). These studies suggest that about
20-25% of all pregnancies normally go unrecognized and
are aborted in the first three weeks after conception.
Little information is available on the causes of these
subclinical pregnancy losses. Such losses, when
recurrent, are frequently misinterpreted as being
difficulties in conceiving. Probably many of these
recurrent losses arise from intrinsic abnormalities of
the early embryo and sometimes this may be secondary to
chromosomal aberration. It is for that reason that
cytogenetic studies are appropriate in couples with
apparent subfertility of long duration.
Early losses. Spontaneous abortion of
recognized pregnancies has been far better studied.
Intrauterine death between the time of pregnancy
recognition and twelve gestational weeks are usually
classed together. In addition to the pre-early losses,
epidemiological studies have demonstrated that about
20-25% of all recognized pregnancies are miscarried in
the first trimester. Studies of cause have demonstrated
that between 50 and 75% of such embryos have demonstrable
cytogenetic abnormalities. Most of these arise from
accidental, nondisjunctional processes in egg or sperm
formation. The most common resulting abnormalities are
various trisomies (with the most common being trisomy 16
which is never seen in liveborns) and monosomy X.
Triploidy, which results from simultaneous fertilization
by two sperm, is also very common in this group.
What evaluation is justifiable following such an early
loss? Given that more than a quarter of recognized
pregnancies end in miscarriage, extensive assessment is
probably not warranted. Morphological evaluation appears
to be of little benefit in assessing possibilities for
recurrence. One could argue that cytogenetic evaluation
of the products of conception (only) can provide
information helpful to the family. About 50-60% of the
time a cytogenetic abnormality without any risk for
recurrence will be demonstrated. And, paradoxically,
empiric recurrence risks are less in next pregnancies
when such a cytogenetic aberration is demonstrated
(presumably because these chromosome problems are truly
chance events while other causes genetic or
maternal may imply greater risk for a similar
outcome in subsequent pregnancies.) Rarely, a
translocational aberration will be discovered which
implies very high risks in next pregnancies. While
justifiable, routine cytogenetic testing in these
circumstances has not become a usual standard of care.
Only when three or more first trimester spontaneous
abortions have occurred do most physicians feel that
comprehensive assessment is justified. This justification
is principally numerical. That is, if spontaneous
abortions arise once in every 4 pregnancies, then the
probability of occurrence in anyone is: 1/4 for one
miscarriage; 1/16 for two miscarriages; 1/64 for three
(consecutive) miscarriages. Thus, after three
miscarriages the 2% probability of this arising purely by
chance is low enough that specific causes should be
sought. Such assessments usually include chromosomal
evaluation of both parents, hormonal, endocrinologic and
immune assessment of the mother, consideration of
structural uterine studies etc.
Late losses (stillbirth). As we have summarized
elsewhere, comprehensive, nonselective and intensive
search for fetal causes is justifiable in those babies
who die in utero at 20 weeks and beyond. Through thorough
assessment about 40% will be found to have a specific
identifiable cause, of which around 60% of those causes
(25% overall) will be of fetal origin.
Because WiSSP is fundamentally a service program we
have accepted assessments done on fetuses of less than 20
weeks gestation. However, we have not previously
critically assessed whether a different protocol is
appropriate under those circumstances.
Intrauterine Deaths between 13 and 20 Weeks. Relatively
few studies have examined the causes of fetal deaths
during this gestational period (see, for example Gaillard
et al. Arch pathol lab med 117:1022, 1993). For lack of
study the causes of abortion during this period are not
nearly so well defined.
Those studies which have been completed suggest that
the underlying causes of such intrauterine deaths are
distinguishable both from those causing early miscarriage
and from those resulting in stillbirth. Furthermore, two
groups or classes of causes seem to be present and seem
to be distinguishable based upon the length of retention
(that is, the degree of maceration) following
intrauterine death. Infections seem to be exceedingly
frequent, probably accounting for around 40-70% of these
losses. Furthermore, chorioamnionitis most often appears
to precipitate labor very shortly after death of the
fetus. Therefore non-macerated (and minimally macerated)
fetuses who are miscarried at this gestational age are
very likely to either have an infectious cause or to have
no demonstrable cause regardless of how thorough an
assessment is completed. In contrast, fetal causes of all
sorts most often do not result in early expulsion.
Therefore, finding fetal causes which could be of
relevance with respect to subsequent recurrences is far
more likely in the significantly macerated fetus.
Furthermore, it is in just such macerated fetuses that
morphological concomitants of fetal processes are most
difficult to recognize.

Finally, one must decide how aggressively specific
agents of infectious causes should be sought. Data are
scanty concerning this question. Most often,
post-delivery cultures will demonstrate
Mycoplasma/ureaplasma, Streptococcus type B, E. Coli, and
a variety of other potential pathogens. Culture
information may be of some benefit in maternal management
and, primarily for this purpose is justifiable. There is
no evidence that routine viral culturing is cost
effective.
On the basis of this information, we suggest that a
protocol for evaluation of fetuses dying at 13 through 19
weeks have a primary branch point based upon severity of
maceration (length of retention). A suggested protocol is
shown on the previous page.
Further Reading*
Cowchock FS, Gibas Z, Jackson LG (1993) Chromosome errors
as a cause of spontaneous abortion: the relative
importance of maternal age and obstetric history. Fertil
steril 59:1011-1014.
Gaillard DA, Paradis P, Lallemand AV, Vernet VM,
Carquin JS, Chippaux CG, Visseaux-Coletto BJ (1993)
Spontaneous abortions during the second trimester of
gestation. Arch pathol lab med 117:1022-1026.
Goldenberg RL, Mayberry SK, Copper RL, Dubard MB,
Hauth JC (1993) Pregnancy outcome following a
second-trimester loss. Obstet gynecol
81:444-446.
Hakim RB, Gray RH, Zacur H (1995) Infertility and
early pregnancy loss. Am j obstet gynecol
172:1510-1517.
Kalousek DK, Pantzar T, Tsai M, Paradice B (1993)
Early spontaneous abortion: Morphological and karyotypic
findings in 3,912 cases. Birth defects OAS
29[1]:53-61.
Pauli RM, Reiser CA, Lebovitz R, Kirkpatrick SJ (1994)
Wisconsin stillbirth service program: I. Establishment
and assessment of a community-based program for etiologic
investigation of intrauterine deaths. Am j med genet
50:116-134.
Pauli RM, Reiser CA (1994) Wisconsin stillbirth
service program: II. Analysis of diagnoses and diagnostic
categories in the first 1,000 referrals. Am j med
genet 50:135-153.
|